Abstract
Nervous system diseases in the central nervous system, peripheral nervous system, and autonomic nervous system lead to sensory, motor, consciousness, and autonomic dysfunctions, which are the main manifestations of these diseases. They have a marked impact on a patient’s life and work. In medicine, cinnamon has the function of “nourishing the primary yang, warming the spleen and stomach, removing internal cold, and promoting blood circulation.” Modern research suggests that cinnamon has anti-oxidation, free radical scavenging, anti-inflammation, anti-intermittency, and anti-ulcer effects. Recent studies have shown that cinnamon has a medicinal effect on nervous system diseases, such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Therefore, this chapter summarizes the research progress and potential medicinal value of cinnamon for the treatment of nervous system diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abou El-Ezz D, Maher A, Sallam N, et al. (2018) Trans-cinnamaldehyde modulates hippocampal Nr2 factor and inhibits amyloid beta aggregation in LPS-induced neuroinflammation mouse model[J]. Neuro Chem Res 43(12):2333–2342
Anderson RA, Qin B, Canini F, Poulet L, Roussel AM (2013) Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior brain insulin signaling and Alzheimer-associated changes. PLoS ONE 8(12):e83243
Bae WY, Choi JS, Jeong JW (2018) The neuroprotective effects of Cinnamic aldehyde in an MPTP mouse model of Parkinson’s disease. Int J Mol Sci 19(2)
Bonifati V, Oostra BA, Heutink P (2004) Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson’s disease. J Mol Med 82(3):163–174. https://doi.org/10.1007/s00109-003-0512-1
Brahmachari S, Jana A, Pahan K (2009) Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 183(9):5917–5927
Busche MA, Bradley T (2020) Synergy between amyloid-β and tau in Alzheimer’s disease. Nat Neurosci 23(10):1183–1193
Chan PH (2004) Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res 29(11):1943–1949
Chen YF, Wang YW, Huang WS, Lee MM, Wood WG, Leung YM, Tsai HY (2016) Trans-Cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of Neuroinflammation through attenuation of iNOS, COX-2 expression and NFκ-B signaling pathway. NeuroMolecular Med 18:322–333
Cheng BH, Sheen LY, Chang ST (2014) Evaluation of anxiolytic potency of essential oil and S-(+)-linalool from Cinnamomum osmophloeum ct. Linalool leaves in mice. J Tradit Complement Med 5(1):27–34
de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M et al (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 54(11 Suppl 5):S21–S23
Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S et al (2011) Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. PLoS One 6(1):e16564
Fu Y, Yang P, Zhao Y et al. (2017) Trans-cinnamaldehyde inhibits microglial activation and improves neuronal survival against neuroinflammation in BV2 microglial cells with lipopolysaccharide stimulation[J]. Evid Based Complement Alternat Med 2017:4730878
George RC, Lew J, Graves DJ (2013) Interaction of cinnamaldehyde and epicatechin with Tau: implications of beneficial effects in modulating Alzheimer’s disease pathogenesis. J Alzheimer’s Dis 36(1):21–40. https://doi.org/10.3233/JAD-122113
Huang H, Chen R, Ma H, et al (2018) Quality atributes and chemical composition of commercial cinnamon oils [J]. Qual Assur Saf Crop 1l(1):16
Goldstein LB, Rothwell PM (2010) Advances in prevention and health services delivery 2009. Stroke 41(2). https://doi.org/10.1161/STROKEAHA.109.570531
Jana A, Modi KK, Roy A, Anderson JA, van Breemen RB, Pahan K (2013) Up-Regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders. J Neuroimmune Pharmacol 8(3):739–755. https://doi.org/10.1007/s11481-013-9447-7
Khasnavis S, Pahan K (2012) Sodium Benzoate a metabolite of cinnamon and a food additive upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol 7(2):424–435. https://doi.org/10.1007/s11481-011-9286-3
Lee EJ, Chen HY, Hung YC, Chen TY, Lee MY, Yu SC et al (2009) Therapeutic window for cinnamophilin following oxygen-glucose deprivation and transient focal cerebral ischemia. Exp Neurol 217(1):74–83
Liu H, Zhao M, Yang S et al (2015) (2R, 3S) -Pinobanksin-3-cinnamate improves cognition and reduces oxidative stress in rats with vascular dementia[ J]. J Nat Med 69(3):358–365
Modi KK, Jana M, Mondal S, Pahan K (2015a) Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates ciliary neurotrophic factor in astrocytes and oligodendrocytes. Neurochem Res 40(11):2333–2347
Modi KK, Roy A, Brahmachari S, Rangasamy SB, Pahan K (2015b) Cinnamon and its metabolite sodium benzoate attenuate the activation of p21rac and protect memory and learning in an animal model of Alzheimer’s disease. PLoS One 10(6):e130398
Mondal S, Pahan K (2015) Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy. PLoS One 10(1):e116566
Panickar KS, Polansky MM, Graves DJ, Urban JJ, Anderson RA (2012) A procyanidin type a trimer from cinnamon extract attenuates glial cell swelling and the reduction in glutamate uptake following ischemia-like injury in vitro. Neuroscience 202:87–98
Ramshini H, Ebrahim-Habibi A, Aryanejad S, Rad A (2015) Effect of Cinnamomum Verum extract on the amyloid formation of hen egg-white lysozyme and study of its possible role in Alzheimer’s disease. Basic Clin Neurosci 6(1):29–37
Ronit S, Dan D, Moran F, Michael O, Daniel S, Ehud G (2012) Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson’s disease model by cinnamon extract, Biochimica et Biophysica Acta (BBA). General Sub 1820,10(1628–1635):0304–4165
Saeideh M, Shokoufeh H, Fazlullah K, Mojtaba Z, Mohammad A (2018) Cinnamon, a promising prospect towards Alzheimer’s disease. Pharmacol Res 130(241–258):1043–6618
Sohrabi R, Pazgoohan N, Seresht HR, Amin B (2017) Repeated systemic administration of the cinnamon essential oil possesses anti-anxiety and anti-depressant activities in mice. Iran J Basic Med Sci 20(6):708–714
Tsai KD, Cherng J, Liu YH, Chen TW, Wong HY, Yang SM et al (2016) Cinnamomum verum component 2 – methoxycinnamaldehyde: a novel antiproliferative drug inducing cell death through targeting both topoisomerase I and II in human colorectal adenocarcinoma COLO 205 cells. J Food Nutr Res 60. https://doi.org/10.3402/fnr.v60.31607
Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42(11):3323–3328
Acknowledgments
We appreciate the research was funded by the China Agriculture Research System (CARS-46) and the major project of the Scientific and Technological R & D of Hubei Agricultural Scientific and Technological Innovation Center (2020-620-000-002-03).
Conflict of Interest
There are no conflicts of interest in this work.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ju, J., Santana de Oliveira, M., Qiao, Y. (2023). The Application Potential of Cinnamon in Neuroprotection. In: Cinnamon: A Medicinal Plant and A Functional Food Systems. Food Bioactive Ingredients. Springer, Cham. https://doi.org/10.1007/978-3-031-33505-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-031-33505-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-33504-4
Online ISBN: 978-3-031-33505-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)